Facts & Figures

Merz Pharma Group

Merz is a privately held pharmaceutical company based in Frankfurt, Germany with affiliates across Europe, as well as the US, Canada, Mexico, Brazil and Asia Pacific. The company is active in research, development and distribution of innovative products in the areas of aesthetic medicine and neurologically induced movement disorders.

In German-speaking countries, our consumer products segment, Merz Consumer Care, is a leading provider of innovative health, wellness and beauty products with its well-known tetesept® and Merz Spezial® brands.

Facts & figures

Global Headquarters:Frankfurt am Main, Germany
Affiliates: Argentina, Australia, Austria, Brazil, Canada, China, Colombia, France, Germany, Great Britain, Hong Kong, India, Indonesia, Italy, Malaysia, Mexico, Philippines, Russia, Singapore, Spain, South Korea, Switzerland, Taiwan, Thailand, The Netherlands, United Arab Emirates, USA, Vietnam
Status: Privately held
Fiscal Year: July 1 – June 30

MERZ Pharma Group key figures

2016/ 20172015/ 2016Change %
RevenueEUR*1.023,21.092,9-6,4%
Thereof:
EMEAEUR*384,7352,49,2%
North AmericaEUR*292,3377,0-22,5%
Latin AmericaEUR*70,155,127,2%
APACEUR*94,981,017,2%
Licenses / CorporateEUR*181,2227,4-20,3%
Results of operations
EBITEUR*99,0131,8-24,9%
EBIT margin%9,712,0
EBT EUR*110,1111,6-1,3%
Net income EUR*59,870,6-15,3%
Cash flow from operating activities EUR*125,8200,3-37,2%
Research and development
Research and development expenses EUR*146,5160,2-8,6%
As % of revenue % 14,314,7
Financial position & net assets
Total assets EUR*1.543,31.510,22,2%
Employees
Headcount as of the end of the reporting period 2.9773.005-0,9%

*EUR in millions

Image brochure